LENALIDOMID Viatris caps 15 mg 21 pce

7680685570055 CH-68557 L04AX04 07.16.4.

Reimbursement limitations:

LENALI.VI.09

LENALIDOMID VIATRIS en association avec l’ixazomib et la dexaméthasone
Après accord sur la prise en …

LENALIDOMID Viatris caps 15 mg 21 pce
LENALIDOMID Viatris caps 15 mg 21 pce
LENALIDOMID Viatris caps 15 mg 21 pce
1 / 3
google

Details

Product number
6855705
CPT
-
Packaging group
21
Unit
Kapsel(n)
Composition
lenalidomidum 15.0 mg, amylum pregelificatum, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, natrii stearylis fumaras, Kapselhülle: titanii dioxidum, gelatina, Drucktinte: lacca, E 172 (rubrum), propylenglycolum, simeticonum, pro capsula corresp. natrium 0.986 mg.

Articles (1)

Lenalidomid Viatris 15 mg, Hartkapseln
Kapseln
21
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
09/08/2024
Patient information leaflet
Français
09/08/2024
Patient information leaflet
Italien
09/08/2024
Professional SmPC
Allemand
09/08/2024
Professional SmPC
Français
09/08/2024
Professional SmPC
Italien
09/08/2024

Detailed composition

Substance Quantity Type Category
(N/A)
15.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
0.986 MG Substance HBESI

Reimbursement information

Public price
CHF 867.75
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/09/2023

Authorization holder

Viatris Pharma GmbH

6312 Steinhausen

Authorization information

Swissmedic authorization number
68557
Drug name
Lenalidomid Viatris, Hartkapseln
Galenic form
KAHA
ATC Code
L04AX04
Authorization status
Z
Dispensation category
A
First authorization
04/04/2022
Authorization expiration date
03/04/2027
IT number
07.16.4.
Domain
Human medicine
Field of application
Onkologikum

Packaging details

Description (FR)
LENALIDOMID Viatris caps 15 mg 21 pce
Description (DE)
LENALIDOMID Viatris Kaps 15 mg 21 Stk
Market launch
04/04/2022
Narcotic (BTM)
No

Original drug

REVLIMID, Hartkapseln
CHF 2480.50
View original

Other packaging sizes

LENALIDOMID Viatris caps 2.5 mg 21 pce
21 KAP
View
LENALIDOMID Viatris caps 5 mg 21 pce
21 KAP
View
LENALIDOMID Viatris caps 7.5 mg 21 pce
21 KAP
View
LENALIDOMID Viatris caps 10 mg 21 pce
21 KAP
View
LENALIDOMID Viatris caps 20 mg 21 pce
21 KAP
View
LENALIDOMID Viatris caps 25 mg 21 pce
21 KAP
View